Introduction
This first ISAG DLA Nomenclature report considers the rules for acceptance of DLA genes and alleles, together with an appropriate sequence based nomenclature. Names have been assigned to existing sequences, where appropriate. The report also includes sequence alignments (both nucleotide and amino acid) for DLA class II alleles, including data which has not been previously published.
There is a table for each class II locus, which lists all published and unpublished sequence data, with accession numbers and references, plus equivalents for new and previously used allele names.
The Committee would like to acknowledge the contribution of the IUIS Committee on Nomenclature of DLA Determinants (Vriesendorp et al. 1977 ) (a subcommittee of the Nomenclature Committee of the International Union of Immunological Societies), which started this work over 20 years ago.
Klein (Klein et al. 1990) proposed the use of the term Cafa (from Canis familiaris) to describe the class I and II genes in the dog MHC region. However, many publications before and since have continued to use the term DLA. The Nomenclature Committee has affirmed the use of the term DLA. This proposal has the approval of Dr Ronald Bontrop, the editor of the journal Immunogenetics, who maintains the register of MHC symbols for all species.
Assignment of DLA gene names

Class I
The assignment of official names for the class I genes has been considered by the committee. Studies suggest that four class I genes can be transcribed, and Table 1 lists those that have been identified to date.
Evidence from other species; cattle, horse, mouse, rat, suggests that there are different numbers of class I genes on different haplotypes. In cattle there are no clear locus specific characteristics so that it is not possible to assign alleles to particular loci just from the sequence data (S. Ellis, personal communication).
Although there appear to be locus specific characteristics which distinguish the different dog class I genes, the Committee considers it premature to assign official DLA names to these genes and needs to examine more data before naming the genes. Evidence from family studies may be needed in the dog to confirm that particular alleles belong to the same allelic series, and more data on the mapping of genes in the dog MHC is necessary.
The original serological data in the dog may have to be ignored, as it was assumed that there were three expressed class I alleles, whereas later evidence (Deeg et al. 1982; Doxiadis et al. 1989) showed that the originally defined DLA-B locus codes for a class II molecule, thus making the serology difficult to interpret. An attempt will be made to correlate the original serological data with the current molecular data, by DNA sequencing some of the class II alleles from dogs used in the serology studies of the First, Second and Third Canine Immunology workshops (Vriesendorp et al. 1973 (Vriesendorp et al. , 1976 Deeg et al. 1986; Bull et al. 1987) .
Class II
Within the dog class II region, clear homologues have been identified for human HLA-DRA, HLA-DRB, HLA-DQA and HLA-DQB genes. These will be named similarly, but the numbering of genes will be sequential, based on those numbers already in common use, and with no attempt to co-ordinate numbers between dog and human homologues. Thus DLA-DRB1 may or may not be a homologue of HLA-DRB1, as the identification of exact gene homologues may require considerably more sequence data than is currently available. 
Rules for naming alleles
The nomenclature described in this report is largely based on the HLA nomenclature system (Bodmer et al. 1997) , and the Bovine Leukocyte Antigen (BoLA) system (Davies et al. 1997) . However, we have decided to name alleles sequentially within a locus if they exhibit any polymorphism within defined hypervariable regions. This decision was taken for several reasons. Firstly, data from other species suggest that alleles which share HVRs also share antigen binding specificity and thus have functional similarity. Although there are no functional data nor crystalline structures yet available for the MHC loci of the dog, it seems reasonable to assume that these data will prove similar to those in other species, if, and when, such data does become available. Secondly, it was felt that since any coding change in any of the HVR might cause the binding of a different peptide, then any such coding difference should result in a different major type allele name. Thirdly, the human HLA nomenclature system (and also to some extent the BoLA nomenclature system), was originally based on serological data, which has resulted in the naming of class II major types to be mainly based on the first HVR. Also, the assignment of a new HLA-DRB allele, for example, may often take into consideration the serological data for that allele. There are no such serological data currently available for any of the dog MHC loci. Fourthly, although the concept of naming related alleles in some sort of hierarchical system is very attractive, there is no clear way in which this can be meaningfully done for the dog MHC at the current time. We have considered the use of dendograms to aid such a naming system for major types, but found that this tended to base the assignment of major types on the first HVR only. Since we wanted a system based on all three HVR, this was not acceptable to the committee. Fifthly, a precedent for such a system for naming alleles already exists in the human HLA nomenclature, for HLA-DPB, where a system based on six variable regions is used. The extent of the HVR is well known for HLA-DRB1, but has not been defined for other HLA loci. We defined the HVR in DLA-DRB1 to be the same as those in HLA-DRB1. The DLA-DQB1 gene is very like DLA-DRB1, and thus we defined very similar regions as the HVR. For DLA-DQA1, which is much less variable, we selected the most polymorphic areas as the HVR. The extent of these regions are given in Table 2 .
This system for naming alleles will result in more major types than in the HLA or BoLA systems. Since the current HLA system may soon run out of new allele numbers for some loci (e.g. HLA-DPB), we have introduced the use of an extra digit in the allele names, as compared to HLA and BoLA.
The rules used for the establishment of allele names are:
1. Names will be based on the amino acid sequences.
2. Allele names will consist of five or six digits; the first three digits indicating the major type, the fourth and fifth digits indicating the subtype, and the sixth digit (if 55 Nomenclature for the DLA system 1998 present) indicating non-expressed variation (silent substitutions). To aid recognition of DLA alleles, we recommend that alleles should be verbalized as in the following example: DRB1*01501 =``DRB1* zero-15, zero-one''.
3. Class I alleles within a single major type will be identical for the three hypervariable regions (HVR) in exons 2 and 3. Differences outside the HVR will be indicated as subtypes of the major type.
4. Class II alleles within a single major type will be identical for the three HVR in exon 2. Differences outside the HVR will be indicated as subtypes of the major type.
5. If a name is given on the basis of a partial sequence the first full length sequence that includes the original partial sequence will assume the allele name.
6. If minor sequence errors are identified the sequence will be corrected.
Assignment of names to be published and new alleles
Using the above guidelines, and the HVR definitions, each locus was considered in turn, and allele names were assigned.
Class I
No official names for the class I alleles will be given until it has been clarified that they all belong to the allelic series as published (Burnett & Geraghty 1995; Burnett et al. 1997; Graumann et al. 1998) .
Class II
Nucleotide and amino acid alignments are given for DLA-DRB1, DQA1 and DQB1, in Figs 1±6 .
References and accession numbers for each sequence for DRB1, DQA1 and DQB1, are given in Tables 3±5. The equivalents for all previous names are also indicated. Due to some partial sequences, some of the equivalents for DQB are probable rather than definite. DRB1 references: (Sarmiento et al. 1990; Wagner et al. 1996c; Francino et al. 1997; Kennedy et al. 1998) , J. M. Angles confirmatory sequence for DRB1*02401 (personal communication).
DQA1 references: (Sarmiento et al. 1992; Wagner et al. 1996a; Polvi et al. 1997) .
DQB1 references: (Sarmiento et al. 1993; Polvi et al. 1997; Wagner et al. 1998a) . Conditions for acceptance of new sequences 1. For class I genes full length exon 2 and exon 3 sequences are required.
2. For class II genes the sequence for the first domain (exon 2) must be included.
3. Sequencing should be performed on both strands of the template DNA.
4. Where a sequence is obtained from cDNA or where PCR products are subcloned prior to sequencing, a minimum of three clones must be sequenced. Alternatively, identical sequences from two different dogs are acceptable. 
57
Nomenclature for the DLA system 1998 5. If direct sequencing of PCR amplified material is performed from a homozygous animal, products from at least two separate PCR reactions should be sequenced.
6. If direct sequencing of PCR amplified material is performed from a heterozygous animal, products from at least two separate PCR reactions should be sequenced, and the sequence should also be confirmed by cloning and sequencing.
7. Where possible sequences should be confirmed by another laboratory.
8. An accession number in a nucleotide sequence database should be obtained.
9. Submission of a sequence to the Nomenclature Committee should include a computerreadable copy of the sequence. 10. DNA (if possible from an animal homozygous for the allele), should be made available for a central repository maintained by the Nomenclature Committee. This DNA will be amplified and made available as reference material for other researchers.
Submission of new sequences
Sequences of new DLA genes or alleles should be submitted to the chairman of the DLA Nomenclature Committee, Lorna Kennedy, to receive official names. The sequence data or accession number(s) should be sent by e-mail: to the address given. Electronic submissions of sequence data are preferred. All sequence information will remain confidential until published or available on sequence databases. The Committee encourages the use of DLA as a keyword to ensure sequences may be found in database searches.
The use of numbers or names for alleles, genes or specificities which pre-empt formal designations such as:``DLA-E'',``DQA1*00401'' or``DLA-DM'' before consideration by the Nomenclature Committee is strongly discouraged.
Sequence database
The committee plans to establish a database of DLA allele sequences which would also include other data, such as how the sequence was obtained, and how many clones were sequenced, etc. We will also record the breed of dog in which the sequence was found. This data will not be made public at this time, however, as such information may cause assumptions to be made about the restriction of particular alleles to certain breeds. (This is in keeping with the policy of the human HLA nomenclature committee, which also records the ethnic origin of all sequences submitted, but does not release that information.) Most of the DLA alleles listed in this report have been found in more than one breed, and many have been found in most breeds tested (n = 60). To date, only one allele (DLA-DRB1*02401) has been found to be limited to a single breed (Japanese Akita). However, as there are over 250 known breeds, there are still many breeds that have not been sampled, so DRB1*02401 may yet be found in another breed.
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